NCT00036920View on ClinicalTrials.gov

TLK286 in Treating Patients With Advanced Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2002

Primary Completion Date

August 31, 2002

Study Completion Date

December 31, 2009

Conditions
Lung Cancer
Interventions
DRUG

canfosfamide hydrochloride

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00036920 - TLK286 in Treating Patients With Advanced Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter